and , manufacturers of the two most popular used vaccines in the United States and much of the rest of the world, are expecting to bring in $51 billion in vaccine sales this year, according to earnings statements published by the companies.Pfizer expects to lead the way, with $32 billion in expected sales, with Moderna projecting $19 billion in revenue from its Covid shots.Almost all of these sales are coming from the developed world, with major nations like the U.S., the UK, and others having surplus of vaccines while many developing countries struggling to get their hands on the shots.
Load More
Load More
